Mark Taylor

5.8k citations
117 papers · 4.1k · 2 hit papers · h-index 30

Impact in

  • Hepatology top 2%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 5%
    • Pancreatic and Hepatic Oncology Research
    • COVID-19 and healthcare impacts

Papers in

Mark Taylor

114 papers receiving 3.9k citations

Mark Taylor's Hit Papers

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134 2022 · 310 citations
3100+3+6Years since publication100200300400500

Peers

Mark Taylor
Comparison fields: 5 of 149
  • Hepatology 518
  • Oncology 1.0k
  • Animal Science and Zoology 248
  • Biotechnology 167
  • Biomaterials 255
Replace Fabrizio Marcucci with:
Fabrizio Marcucci Italy
Chi-Hung Lin Taiwan
Chih‐Ching Wu Taiwan
Xin Xiao Zheng United States
Ni Tang China
R Tauber Germany
Kerstin Steinbrink Germany
John A. Barnard United States
Cai Zhang China
Marc Aprahamian France
Mark Taylor relative to Fabrizio Marcucci Italy Fabrizio Marcucci's profile →
Citations per field
00.5×2×4×5.8×
Fabrizio Marcucci · 1×
Citations per year

Countries citing papers authored by Mark Taylor

Since Specialization
Citations

This map shows the geographic impact of Mark Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Taylor more than expected).

Fields of papers citing papers by Mark Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Taylor. The network helps show where Mark Taylor may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Taylor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Taylor Line = papers co-authored together Mark Taylor links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Southampton Consensus Guidelines for Laparoscopic Liver Surgery
Hit paper breakdown →
2017551
2 1991345
3
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134
Hit paper breakdown →
2022310
4 2021214
5 1988147
6 2015137
7 2007126
8 2017104
9 1995104
10 1984102
11 2018101
12 199698
13 198787
14 200471
15 198768
16
Sinistral portal hypertension.
200667
17 201554
18 199052
19 200251
20 201750

About Mark Taylor

Mark Taylor is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Surgery and Biotechnology, having authored 117 papers that have together received 4.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (14 papers), Gallbladder and Bile Duct Disorders (9 papers), Ultrasound and Hyperthermia Applications (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Enzyme Production and Characterization (5 papers), Pediatric Hepatobiliary Diseases and Treatments (5 papers), Pancreatitis Pathology and Treatment (5 papers) and Nanoplatforms for cancer theranostics (4 papers). The work is most often cited by research in Hepatology (518 citations), Oncology (1.0k citations), Animal Science and Zoology (248 citations), Biotechnology (167 citations) and Biomaterials (255 citations). Mark Taylor has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include David J. Etherington, Ruth M. Starzyk, Bernard Malfroy, Phillip M. Friden, Gary F. Musso, Lee R. Walus, A. P. McHale, John F. Callan, Heather Nesbitt and Robert W. Mason. Their work appears in journals such as HPB, European Journal of Gastroenterology & Hepatology, Journal of Controlled Release, Protein Engineering Design and Selection and Meat Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact